Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Interest Expenses (2016 - 2021)

Sonoma Pharmaceuticals has reported Interest Expenses over the past 12 years, most recently at $1000.0 for Q2 2021.

  • For Q2 2021, Interest Expenses changed N/A year-over-year to $1000.0; the TTM value through Mar 2022 reached $1000.0, down 88.89%, while the annual FY2021 figure was $12000.0, 25.0% down from the prior year.
  • Interest Expenses for Q2 2021 was $1000.0 at Sonoma Pharmaceuticals, down from $5000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $12000.0 in Q2 2018 and troughed at $1000.0 in Q1 2017.
  • A 5-year average of $6250.0 and a median of $7000.0 in 2018 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: surged 900.0% in 2017 and later tumbled 85.71% in 2019.
  • Year by year, Interest Expenses stood at $11000.0 in 2017, then crashed by 36.36% to $7000.0 in 2018, then plummeted by 85.71% to $1000.0 in 2019, then soared by 400.0% to $5000.0 in 2020, then plummeted by 80.0% to $1000.0 in 2021.
  • Business Quant data shows Interest Expenses for SNOA at $1000.0 in Q2 2021, $5000.0 in Q4 2020, and $4000.0 in Q3 2020.